机构ID,机构名称,公告日期,开始日期,截止日期,报告年度,合并类型,报表来源,销售商品、提供劳务收到的现金（元）,收到的税费返还,收到其他与经营活动有关的现金,经营活动现金流入小计,购买商品、接受劳务支付的现金,支付给职工以及为职工支付的现金,支付的各项税费,支付其他与经营活动有关的现金,经营活动现金流出小计,经营活动产生的现金流量净额,收回投资收到的现金,取得投资收益收到的现金,处置固定资产、无形资产和其他长期资产收回的现金净额,处置子公司及其他营业单位收到的现金净额,收到其他与投资活动有关的现金,投资活动现金流入小计,购建固定资产、无形资产和其他长期资产支付的现金,投资支付的现金,质押贷款净增加额,取得子公司及其他营业单位支付的现金净额,支付其他与投资活动有关的现金,投资活动现金流出小计,投资活动产生的现金流量净额,吸收投资收到的现金,取得借款收到的现金,发行债券收到的现金,收到其他与筹资活动有关的现金,筹资活动现金流入小计,偿还债务支付的现金,分配股利、利润或偿付利息支付的现金,支付其他与筹资活动有关的现金,筹资活动现金流出小计,筹资活动产生的现金流量净额,四、汇率变动对现金的影响,四(2)、其他原因对现金的影响,五、现金及现金等价物净增加额,期初现金及现金等价物余额,期末现金及现金等价物余额,附注：,1、将净利润调节为经营活动现金流量：,净利润,加：资产减值准备,固定资产折旧、油气资产折耗、生产性生物资产折旧,无形资产摊销,长期待摊费用摊销,处置固定资产、无形资产和其他长期资产的损失,固定资产报废损失,公允价值变动损失,财务费用,投资损失,递延所得税资产减少,递延所得税负债增加,存货的减少,经营性应收项目的减少,经营性应付项目的增加,其他,经营活动产生的现金流量净额2,2、不涉及现金收支的重大投资和筹资活动：,债务转为资本,一年内到期的可转换公司债券,融资租入固定资产,3、现金及现金等价物净变动情况：,现金的期末余额,减：现金的期初余额,加：现金等价物的期末余额,减：现金等价物的期初余额,加：其他原因对现金的影响2,现金及现金等价物净增加额2,客户存款和同业存放款项净增加额,向中央银行借款净增加额,向其他金融机构拆入资金净增加额,收到原保险合同保费取得的现金,收到再保险业务现金净额,保户储金及投资款净增加额,处置以公允价值计量且其变动计入当期损益的金融资产净增加额,收取利息、手续费及佣金的现金,拆入资金净增加额,回购业务资金净增加额,客户贷款及垫款净增加额,存放中央银行和同业款项净增加额,支付原保险合同赔付款项的现金,支付利息、手续费及佣金的现金,支付保单红利的现金,其中：子公司吸收少数股东投资收到的现金,其中：子公司支付给少数股东的股利、利润,投资性房地产的折旧及摊销
2826,易明医药,2016-11-14,2016-01-01,2016-06-30,2016-06-30,合并本期,招募说明书,258419062.96,0.0,22897407.01,281316469.97,87971938.79,36829905.73,38928691.89,84623344.27,248353880.68,32962589.29,33000000.0,36553.42,11149.91,,,33047703.33,10533969.58,33000000,,,,43533969.58,-10486266.25,0.0,,,0.0,,1000000.0,1662164.25,0.0,2662164.25,-2662164.25,-6035.77,,19808123.02,38147383.17,57955506.19,,,24577509.87,913710.22,3148262.56,619235.72,148987.08,474868.75,,,2392250.0,-36553.42,1104057.12,,5751189.81,-9478673.02,3432744.6,-85000.0,32962589.29,,,,,,57955506.19,38147383.17,,,,19808123.02,,,,,,,,,,,,,,,,,,
2826,易明医药,2016-11-14,2016-01-01,2016-09-30,2016-09-30,合并本期,招募说明书,,0.0,0.0,,,,0.0,0.0,,242700.0,,0.0,,,,,,0,,,,,-11913600.0,0.0,,,0.0,,,,0.0,,-3615200.0,,,-15292100.0,,22855300.0,,,,,0.0,,0.0,,,,0.0,,,,,,,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2826,易明医药,2017-03-30,2016-01-01,2016-12-31,2016-12-31,合并本期,定期报告,619486521.69,,35269649.62,654756171.31,247541408.88,70754927.13,76640903.61,202639530.34,597576769.96,57179401.35,33000000.0,36553.42,11149.91,,,33047703.33,18521584.39,33000000,,,,51521584.39,-18473881.06,266225800.0,10000000.0,,,276225800.0,60000000.0,3499530.08,8239102.86,71738632.94,204487167.06,-18197.41,,243174489.94,38147383.17,281321873.11,,,55358450.89,5095722.78,6143865.95,1266058.82,297974.16,474868.75,,,4904671.93,-36553.42,647842.26,,8685043.98,-16288857.34,-9199687.41,-170000.0,57179401.35,,,,,,281321873.11,38147383.17,,,,243174489.94,,,,,,,,,,,,,,,,,,
2826,易明医药,2017-04-24,2017-01-01,2017-03-31,2017-03-31,合并本期,定期报告,146484292.21,,24480055.35,170964347.56,58742378.34,16219518.16,10407859.79,62334459.94,147704216.23,23260131.33,,,150500.0,,,150500.0,41473662.75,100000000,,,,141473662.75,-141323162.75,,,,1063333.33,1063333.33,,384808.51,,384808.51,678524.82,,,-117384506.6,281321873.11,163937366.51,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2826,易明医药,2017-08-19,2017-01-01,2017-06-30,2017-06-30,合并本期,定期报告,295665947.64,,33959707.94,329625655.58,123289628.93,33860073.0,25956865.25,112328078.74,295434645.92,34191009.66,110000000.0,771268.89,150500.0,,810000.0,111731768.89,47803016.19,210000000,,,,257803016.19,-146071247.3,,,,1063333.33,1063333.33,,11253595.94,,11253595.94,-10190262.61,,,-122070500.25,281321873.11,159251372.86,,,21331488.83,-2120418.26,3683274.93,657741.83,196090.64,-82638.46,,0.0,444864.07,-771268.89,310323.39,0.0,-3536803.82,-17599746.46,31769851.86,-91750.0,34191009.66,,,,,,159251372.86,281321873.11,,,,-122070500.25,,,,,,,,,,,,,,,,,,
2826,易明医药,2017-10-24,2017-01-01,2017-09-30,2017-09-30,合并本期,定期报告,409599422.23,,37653848.45,447253270.68,154383380.47,49717378.37,38034924.54,181371305.96,423506989.34,23746281.34,210000000.0,1546638.76,150500.0,,810000.0,212507138.76,53052092.46,330000000,,,,383052092.46,-170544953.7,,,,1063333.33,1063333.33,,11888119.58,,11888119.58,-10824786.25,,,-157623458.61,281321873.11,123698414.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
